Pharmacology & ToxicologyJournal of Clinical Pharmacy and TherapeuticsPeer-reviewed
A Study on the Pharmacokinetic/Pharmacodynamic Profiles of the Novel PPAR Pan Agonist Chiglitazar Sodium in Rats with Hypoalbuminemia
Wenjuan He, Xinhui Zhang, Menghao Li…·Xiuju Liu
This study compares the PK/PD profiles of Chiglitazar Sodium in healthy rats and those with hypoalbuminemia, finding no significant differences except for Tmax.
DOI 10.1155/jcpt/7161985